Abstract:
The invention relates to a silyl-containing polymer that is used, together with a tackifying resin to form an adhesive composition capable of storing and delivering drugs to the skin of a user. Typically the composition is formed into a patch which shows excellent adhesion to the skin even when drugs and other additives are dissolved into the composition.
Abstract:
The present invention relates to a cascade impactor for measuring particle size distribution of an aerosol comprising nicotine, the cascade impactor comprising: an induction port for receiving an inhaler; and at least one sample collection stage comprising a nozzle assembly and a collection means; wherein the collection means of at least one sample collection stage is coated with isopropyl alcohol.
Abstract:
A composition suitable for use in nicotine replacement therapy products includes a nicotine product that includes a synthetic nicotine that is substantially free of one or more contaminants and/or impurities normally associated with tobacco-derived nicotine. For example, the synthetic nicotine is substantially free of one or more of nicotine-1'-N-oxide, nicotyrine, nornicotyrine, 2',3-bipyridyl, cotinine, anabasine, and/or anatabine. The composition further comprises one or more pharmaceutically acceptable excipients, additives and/or carriers. The nicotine replacement therapy products may include any number of such products, including transdermal nicotine delivery patches, nicotine gums, synthetic chewing tobacco, synthetic snuff, and synthetic strips (e.g., dissolvable synthetic tobacco). Additionally, a method of treating nicotine addiction includes administering a nicotine replacement composition, e.g., via a nicotine replacement therapy product, to a user.
Abstract:
Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The enzyme layer protects the enzyme and prevents it from leaching from the sensing membrane into a host or deactivating.
Abstract:
Chewing gum compositions comprising a biologically active ingredients are described, in which the gum compositions have a compression modulus of less than 7 kPa. The gums of the invention exhibit improved patient compliance when compared with prior art gums, as well as offering improved release characteristics of the active ingredient contained therein.
Abstract:
The invention provides novel methods and compositions for diagnosing, treating, and monitoring treatment of Shank3 (SH3 and multiple ankyrin repeat domains 3) deficiency associated disorders.
Abstract:
A smokeless tobacco product or medicinal nicotine product including nicotine and acyl nornicotine. Preferably, the acyl nornicotine is selected from the group consisting of N- Pentanoylnomicotine, N-Hexanoylnornicotine, N-Heptanolynornicotine, N- Octanoylnornicotine, N-Nonanoylnomicotine, N-Decanoylnornicotine, N- Undecanoylnornicotine, and N-Dedecanoylnornicotine. Also disclosed are methods of making such products.
Abstract:
The present invention relates to compositions comprising at least two different active compounds and the use of such combination compositions in medicine, in particular in methods for treating obesity and obesity-related disorders and/or in methods for inhibiting weight gain.
Abstract:
This invention is directed to a method of treating one or more disorders associated with an undesired downstream activity of at least one subtype of neuronal nicotinic acetylcholine receptor, comprising treating a patient with noribogaine, noribogaine derivative, or pharmaceutically acceptable salt or solvate thereof so as to attenuate said undesired effect.
Abstract:
본 발명은 멜라토닌, 덱스판테놀, 비오틴 및 니코틴산아미드를 유효성분으로 포함하는 육모, 양모 또는 발모 촉진용 약제학적 조성물에 관한 것이다. 본 발명의 조성물은 약리 활성성분인 멜라토닌의광안정성을 개선하면서 제제를 안정화시키고 두피 염증을 유의하게 억제함으로써, 발모 또는 양모 효과를 극대화시킨다. 따라서, 본 발명의 조성물은 광안정성, 보존성, 투약 편의성 및 치료효과가 동시에 증대된 효율적인 발모, 양모 촉진제 또는 탈모의 예방 또는 치료제로서 유용하게 이용될 수 있다.